Lam Research Files 8-K
Ticker: LRCX · Form: 8-K · Filed: 2024-05-21T00:00:00.000Z
Sentiment: neutral
Topics: disclosure, corporate-events
Related Tickers: LRCX
TL;DR
LRCX filed an 8-K, check for updates on Reg FD, other events, and financials.
AI Summary
Lam Research Corporation (LRCX) filed an 8-K on May 21, 2024, to report on various events. The filing includes information related to Regulation FD disclosures, other events, and financial statements and exhibits. Specific details regarding the nature of these events or any financial figures were not immediately available in the provided text.
Why It Matters
This filing indicates that Lam Research is disclosing material information to the public, which could impact investor decisions.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure and does not inherently present immediate financial risk.
Key Players & Entities
- LAM RESEARCH CORP (company) — Registrant
- LRCX (company) — Ticker Symbol
- May 21, 2024 (date) — Report Date
FAQ
What specific events are being disclosed under Regulation FD?
The provided text does not specify the exact nature of the Regulation FD disclosures.
Are there any significant 'Other Events' being reported by Lam Research?
The filing indicates 'Other Events' are reported, but the specifics are not detailed in the provided text.
What financial statements or exhibits are included with this 8-K filing?
The filing states that 'Financial Statements and Exhibits' are included, but their content is not described in the provided text.
What is Lam Research Corporation's principal executive office address?
Lam Research Corporation's principal executive offices are located at 4650 Cushing Parkway, Fremont, California 94538.
What is the filing date of this 8-K report?
The report was filed on May 21, 2024.
Filing Stats: 728 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-05-21 07:30:11
Key Financial Figures
- $0.001 — ich registered Common Stock, Par Value $0.001 Per Share LRCX The Nasdaq Stock Market
- $10 billion — ompany's press release also announced a $10 billion share repurchase authorization. The for
Filing Documents
- lrcx-20240521.htm (8-K) — 40KB
- lrcx_exx991xmayx21x2024.htm (EX-99.1) — 9KB
- 0000707549-24-000076.txt ( ) — 174KB
- lrcx-20240521.xsd (EX-101.SCH) — 2KB
- lrcx-20240521_lab.xml (EX-101.LAB) — 21KB
- lrcx-20240521_pre.xml (EX-101.PRE) — 12KB
- lrcx-20240521_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure 3
01. Other Events
Item 8.01. Other Events 3
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits 3 SIGNATURES 4 EX-99.1 Table of Contents
01. Results of Operations and Financial Condition
Item 7.01. Results of Operations and Financial Condition On May 21, 2024, Lam Research Corporation (the "Company") issued a press release announcing that the Company's Board of Directors has authorized a 10-for-1 forward split (the "Stock Split") of its common stock, par value $0.001 per share (the "Common Stock"), to be effected through an amendment to the Company's Restated Certificate of Incorporation (the "Amendment") filed with the Secretary of State of the State of Delaware, which is expected to be filed after the close of trading on October 2, 2024. The Amendment will also effect a proportionate increase in the number of shares of authorized Common Stock, and is expected to become effective at 5:00 p.m. Eastern Time on the date of its filing with the Secretary of State of the State of Delaware. Trading in the Common Stock is expected to commence on a split-adjusted basis on October 3, 2024. The press release is attached hereto as Exhibit 99.1. The information in Item 7.01 of this Form 8-K is being furnished under Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of such section, nor shall it be deemed incorporated by reference in any filing of the Company under theSecurities Act of 1933, as amended, or theExchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01. Other Events
Item 8.01. Other Events The Company's press release also announced a $10 billion share repurchase authorization. The foregoing description of the share repurchase authorization is qualified in its entirety by reference to the full text of Exhibit 99.1 incorporated by reference in this Item 8.01.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits 99.1 Press Release dated May 21, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document Table of Contents
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 21, 2024 LAM RESEARCH CORPORATION (Registrant) /s/ George M. Schisler, Jr. George M. Schisler, Jr. Vice President, Secretary and Chief Legal Officer